Evidence map›Paper›PMID 41161790›Full record

ArticleThe Journal of veterinary medical science2026

Transcriptome analysis of multi-azole-resistant Microsporum canis isolated from a case of feline dermatophytosis.

Kanon Tsurumi, Yuri Oshima, Nobuo Murayama, Koichi Makimura, Rui Kano

Abstract read
In one paragraph

Article in The Journal of veterinary medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kanon TsurumiTeikyo University Institute of Medical Mycology (TIMM), Tokyo, Japan.
Yuri OshimaDermatology Services for Dogs and Cats, Tokyo, Japan.
Nobuo MurayamaDermatology Services for Dogs and Cats, Tokyo, Japan.
Koichi MakimuraTeikyo University Institute of Medical Mycology (TIMM), Tokyo, Japan.
Rui KanoTeikyo University Institute of Medical Mycology (TIMM), Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanism of multi-azole antifungal resistance in the dermatophyte Microsporum canis was investigated through a transcriptome analysis of the multi-azole-resistant strain LLP25-013. Strain LLP25-013 was cultured with and without itraconazole (ITCZ), after which total RNA was extracted from mycelial samples. Whole-RNA sequencing was performed using a DNBSEQ-G400 system. A total of 8,846 expressed genes were detected in samples of both total RNAs from both ITCZ-treated and ITCZ-free samples. Genes sequenced with more than 10,000 reads were selected from ITCZ-treated and ITCZ-free samples, and the expression levels were compared. Treatment with ITCZ upregulated the expression of 63 genes compared with no ITCZ treatment. By contrast, ITCZ treatment downregulated the expression of 253 identified genes. ITCZ addition reduced the expression of many genes in M. canis, which could be related to the broad-spectrum antifungal drug resistance of this organism. Among the upregulated genes, the ATP-binding cassette (ABC) transporter gene is involved in resistance in other dermatophytes. Co-culture of strain LLP25-013 with milbemycin and other azoles suggested that the isolate acquired azole resistance through high expression of the ABC transporter.

Indexed as

Antifungal AgentsAzolesCat DiseasesDrug Resistance, Multiple, FungalMicrosporumTineaAnimalsCatsDrug Resistance, FungalGene Expression ProfilingItraconazoleTranscriptomeAntifungal AgentsAzolesItraconazolegene expressionitraconazoleMicrosporum canismulti-azole resistanttranscriptome analysis

Identifiers

PMID41161790
PMCPMC12950322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.